SCHEMBL17232586

SCHEMBL17232586

CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAX8 Q06710 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ MMP1 P03956 1/20 0.52
▸ MMP3 P08254 1/20 0.52
▸ MMP9 P14780 1/20 0.52
▸ CA1 P00915 3/20 0.52
▸ CA2 P00918 3/20 0.52
▸ FNTA P49354 3/20 0.49
▸ FNTB P49356 3/20 0.49
▸ PGGT1B P53609 3/20 0.49
▸ CTSS P25774 2/20 0.49
▸ CTSK P43235 2/20 0.49
▸ GNPAT O15228 1/20 0.49
▸ CTSL P07711 1/20 0.49
▸ CTSB P07858 1/20 0.49
▸ MAPT P10636 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ FOLH1 Q04609 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17254230 1.00 PAX8 (0.53) PAX8TDP1MMP1MMP3MMP9
SCHEMBL21981320 0.93 REN (0.53) PAX8TDP1MMP1MMP3MMP9
SCHEMBL21981319 0.93 REN (0.53) PAX8TDP1MMP1MMP3MMP9
SCHEMBL17553458 0.93 PAX8 (0.52) PAX8TDP1MMP1MMP3MMP9
SCHEMBL1755615 0.93 TDP1 (0.61) PAX8TDP1MMP1MMP3MMP9
SCHEMBL29683965 0.92 CCKBR (0.50) PAX8TDP1MMP1MMP3MMP9
SCHEMBL13956678 0.92 PAX8 (0.52) PAX8TDP1MMP1MMP3MMP9
SCHEMBL17254256 0.92 TDP1 (0.56) PAX8TDP1MMP1MMP3MMP9
SCHEMBL23352495 0.92 REN (0.56) PAX8TDP1GNPAT
SCHEMBL3387924 0.92 PAX8 (0.53) PAX8TDP1MMP1MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11993629-B2 Method for producing peptide compound NISSAN CHEMICAL CORPORATION (JP) 2024-05-28 — — US disclosed
WO-2023144379-A1 HIGH-AFFINITY LIGANDS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED DELIVERY APPLICATIONS PHILOCHEM AG (CH) 2023-08-03 — — WO disclosed
US-20220106355-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2022-04-07 — — US disclosed
US-20170202975-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-07-20 — — US disclosed
US-20170151346-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-06-01 — — US disclosed
US-20150314017-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD (CN) 2015-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170151346-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM PAX8 1160/4885TDP1 2250/4885MMP1 3941/4885
US-20170202975-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM PAX8 1160/4885TDP1 2250/4885MMP1 3941/4885
US-11993629-B2 Method for producing peptide compound VIP, NGLY1, IAPP PAX8 4409/4885TDP1 3840/4885MMP1 3065/4885
US-20150314017-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM PAX8 1160/4885TDP1 2250/4885MMP1 3941/4885
US-20220106355-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND VIP, NGLY1, IAPP PAX8 4409/4885TDP1 3840/4885MMP1 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback